Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    LB 100

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    LIXTE Levels Up From PP2A Innovation To Multi-Modal Oncology
    LIXTE Levels Up From PP2A Innovation To Multi-Modal Oncology

    03 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-03/lixte-levels-up-from-pp2a-innovation-to-multi-modal-oncology

    PHARMIWEB
    03 Dec 2025
    Share Share
    LIXTE Steps Into A Key Role In The Rise Of Treatment Amplifiers
    LIXTE Steps Into A Key Role In The Rise Of Treatment Amplifiers

    03 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-03/lixte-steps-into-a-key-role-in-the-rise-of-treatment-amplifiers

    PHARMIWEB
    03 Dec 2025
    Share Share
    Lixte Bio to Present at Spartan Capital Investor Conference 2025
    Lixte Bio to Present at Spartan Capital Investor Conference 2025

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176386/0/en/LIXTE-Biotechnology-Holdings-to-Present-at-the-Spartan-Capital-Investor-Conference-2025-November-3.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    LIXTE Focuses On Lead Candidate LB-100, Advancement Development
    LIXTE Focuses On Lead Candidate LB-100, Advancement Development

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3167869/0/en/LIXTE-Biotechnology-Holdings-Highlights-Q4-2025-Priorities-Including-Ongoing-Advancement-of-Lead-Candidate-LB-100-Strategic-Oncology-Business-Development-and-Acquisition-Plans.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share
    Lixte Unveils Plan to Redefine Cancer's Master Switch on Nasdaq
    Lixte Unveils Plan to Redefine Cancer's Master Switch on Nasdaq

    16 Sep 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/lixtes-bold-blueprint-to-rewire-cancers-master-switch-and-redefine-its-own-future-nas-1074108

    ACCESSWIRE
    16 Sep 2025
    Share Share
    Lixte Bio's Summer Sees Leadership Updates, Scientific Progress
    Lixte Bio's Summer Sees Leadership Updates, Scientific Progress

    15 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-15/lixte-bios-transformational-summer-marked-by-leadership-updates-scientific-progress-and-digital-t

    PHARMAWEB
    15 Sep 2025
    Share Share